Intrinsic value of Universal Health Services Cl B - UHS

Previous Close

$118.09

  Intrinsic Value

$126.96

stock screener

  Rating & Target

hold

+8%

Previous close

$118.09

 
Intrinsic value

$126.96

 
Up/down potential

+8%

 
Rating

hold

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of UHS stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  8.00
  5.50
  5.45
  5.40
  5.36
  5.33
  5.30
  5.27
  5.24
  5.22
  5.19
  5.17
  5.16
  5.14
  5.13
  5.11
  5.10
  5.09
  5.08
  5.08
  5.07
  5.06
  5.05
  5.05
  5.04
  5.04
  5.04
  5.03
  5.03
  5.03
  5.02
Revenue, $m
  9,766
  10,303
  10,865
  11,452
  12,066
  12,709
  13,382
  14,087
  14,825
  15,598
  16,408
  17,257
  18,147
  19,080
  20,058
  21,084
  22,160
  23,288
  24,472
  25,714
  27,017
  28,385
  29,819
  31,325
  32,905
  34,564
  36,304
  38,131
  40,049
  42,062
  44,175
Variable operating expenses, $m
 
  8,850
  9,312
  9,795
  10,300
  10,829
  11,382
  11,961
  12,568
  13,204
  13,870
  14,190
  14,921
  15,689
  16,493
  17,336
  18,221
  19,149
  20,122
  21,144
  22,215
  23,339
  24,519
  25,757
  27,056
  28,420
  29,851
  31,353
  32,930
  34,585
  36,323
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  8,485
  8,850
  9,312
  9,795
  10,300
  10,829
  11,382
  11,961
  12,568
  13,204
  13,870
  14,190
  14,921
  15,689
  16,493
  17,336
  18,221
  19,149
  20,122
  21,144
  22,215
  23,339
  24,519
  25,757
  27,056
  28,420
  29,851
  31,353
  32,930
  34,585
  36,323
Operating income, $m
  1,281
  1,453
  1,553
  1,657
  1,766
  1,881
  2,000
  2,125
  2,257
  2,394
  2,538
  3,067
  3,226
  3,391
  3,565
  3,748
  3,939
  4,139
  4,350
  4,571
  4,802
  5,045
  5,300
  5,568
  5,849
  6,144
  6,453
  6,778
  7,119
  7,476
  7,852
EBITDA, $m
  1,698
  2,063
  2,175
  2,293
  2,416
  2,545
  2,679
  2,820
  2,968
  3,123
  3,285
  3,455
  3,633
  3,820
  4,016
  4,221
  4,437
  4,663
  4,900
  5,149
  5,409
  5,683
  5,970
  6,272
  6,588
  6,920
  7,269
  7,635
  8,019
  8,422
  8,845
Interest expense (income), $m
  107
  144
  154
  166
  178
  191
  204
  218
  232
  248
  264
  280
  298
  316
  335
  355
  377
  399
  422
  446
  472
  499
  527
  556
  587
  620
  654
  690
  728
  767
  809
Earnings before tax, $m
  1,156
  1,309
  1,398
  1,491
  1,588
  1,690
  1,796
  1,908
  2,024
  2,146
  2,275
  2,787
  2,928
  3,075
  3,230
  3,392
  3,562
  3,741
  3,928
  4,124
  4,330
  4,547
  4,773
  5,012
  5,261
  5,524
  5,799
  6,088
  6,391
  6,709
  7,043
Tax expense, $m
  409
  354
  378
  403
  429
  456
  485
  515
  547
  580
  614
  753
  791
  830
  872
  916
  962
  1,010
  1,061
  1,114
  1,169
  1,228
  1,289
  1,353
  1,421
  1,491
  1,566
  1,644
  1,726
  1,811
  1,902
Net income, $m
  702
  956
  1,021
  1,088
  1,159
  1,234
  1,311
  1,393
  1,478
  1,567
  1,660
  2,035
  2,137
  2,245
  2,358
  2,476
  2,601
  2,731
  2,867
  3,011
  3,161
  3,319
  3,485
  3,658
  3,841
  4,032
  4,233
  4,444
  4,665
  4,898
  5,142

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  10,318
  10,845
  11,436
  12,055
  12,701
  13,378
  14,086
  14,828
  15,605
  16,419
  17,272
  18,165
  19,102
  20,084
  21,114
  22,194
  23,326
  24,514
  25,760
  27,068
  28,439
  29,879
  31,389
  32,974
  34,637
  36,383
  38,215
  40,138
  42,157
  44,276
  46,500
Adjusted assets (=assets-cash), $m
  10,284
  10,845
  11,436
  12,055
  12,701
  13,378
  14,086
  14,828
  15,605
  16,419
  17,272
  18,165
  19,102
  20,084
  21,114
  22,194
  23,326
  24,514
  25,760
  27,068
  28,439
  29,879
  31,389
  32,974
  34,637
  36,383
  38,215
  40,138
  42,157
  44,276
  46,500
Revenue / Adjusted assets
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
Average production assets, $m
  4,084
  4,307
  4,541
  4,787
  5,044
  5,312
  5,594
  5,888
  6,197
  6,520
  6,859
  7,213
  7,585
  7,975
  8,384
  8,813
  9,263
  9,735
  10,229
  10,749
  11,293
  11,865
  12,465
  13,094
  13,754
  14,448
  15,175
  15,939
  16,740
  17,582
  18,465
Working capital, $m
  364
  464
  489
  515
  543
  572
  602
  634
  667
  702
  738
  777
  817
  859
  903
  949
  997
  1,048
  1,101
  1,157
  1,216
  1,277
  1,342
  1,410
  1,481
  1,555
  1,634
  1,716
  1,802
  1,893
  1,988
Total debt, $m
  4,136
  4,414
  4,744
  5,090
  5,451
  5,829
  6,225
  6,640
  7,074
  7,529
  8,006
  8,505
  9,029
  9,578
  10,154
  10,757
  11,390
  12,054
  12,751
  13,482
  14,249
  15,053
  15,897
  16,783
  17,713
  18,689
  19,713
  20,788
  21,917
  23,101
  24,344
Total liabilities, $m
  5,785
  6,063
  6,393
  6,739
  7,100
  7,478
  7,874
  8,289
  8,723
  9,178
  9,655
  10,154
  10,678
  11,227
  11,803
  12,406
  13,039
  13,703
  14,400
  15,131
  15,898
  16,702
  17,546
  18,432
  19,362
  20,338
  21,362
  22,437
  23,566
  24,750
  25,993
Total equity, $m
  4,533
  4,783
  5,043
  5,316
  5,601
  5,900
  6,212
  6,539
  6,882
  7,241
  7,617
  8,011
  8,424
  8,857
  9,311
  9,787
  10,287
  10,811
  11,360
  11,937
  12,542
  13,176
  13,843
  14,541
  15,275
  16,045
  16,853
  17,701
  18,591
  19,526
  20,506
Total liabilities and equity, $m
  10,318
  10,846
  11,436
  12,055
  12,701
  13,378
  14,086
  14,828
  15,605
  16,419
  17,272
  18,165
  19,102
  20,084
  21,114
  22,193
  23,326
  24,514
  25,760
  27,068
  28,440
  29,878
  31,389
  32,973
  34,637
  36,383
  38,215
  40,138
  42,157
  44,276
  46,499
Debt-to-equity ratio
  0.912
  0.920
  0.940
  0.960
  0.970
  0.990
  1.000
  1.020
  1.030
  1.040
  1.050
  1.060
  1.070
  1.080
  1.090
  1.100
  1.110
  1.120
  1.120
  1.130
  1.140
  1.140
  1.150
  1.150
  1.160
  1.160
  1.170
  1.170
  1.180
  1.180
  1.190
Adjusted equity ratio
  0.437
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  702
  956
  1,021
  1,088
  1,159
  1,234
  1,311
  1,393
  1,478
  1,567
  1,660
  2,035
  2,137
  2,245
  2,358
  2,476
  2,601
  2,731
  2,867
  3,011
  3,161
  3,319
  3,485
  3,658
  3,841
  4,032
  4,233
  4,444
  4,665
  4,898
  5,142
Depreciation, amort., depletion, $m
  417
  610
  623
  636
  650
  664
  679
  695
  712
  729
  747
  388
  408
  429
  451
  474
  498
  523
  550
  578
  607
  638
  670
  704
  739
  777
  816
  857
  900
  945
  993
Funds from operations, $m
  1,365
  1,566
  1,643
  1,724
  1,809
  1,898
  1,990
  2,088
  2,189
  2,296
  2,408
  2,422
  2,545
  2,674
  2,809
  2,950
  3,099
  3,254
  3,417
  3,589
  3,768
  3,957
  4,155
  4,362
  4,580
  4,809
  5,049
  5,301
  5,565
  5,843
  6,134
Change in working capital, $m
  77
  24
  25
  26
  28
  29
  30
  32
  33
  35
  36
  38
  40
  42
  44
  46
  48
  51
  53
  56
  59
  62
  65
  68
  71
  75
  78
  82
  86
  91
  95
Cash from operations, $m
  1,288
  1,542
  1,618
  1,698
  1,781
  1,869
  1,960
  2,056
  2,156
  2,261
  2,371
  2,384
  2,505
  2,632
  2,765
  2,904
  3,050
  3,203
  3,364
  3,533
  3,710
  3,895
  4,090
  4,295
  4,509
  4,734
  4,971
  5,219
  5,479
  5,752
  6,039
Maintenance CAPEX, $m
  0
  -220
  -232
  -244
  -257
  -271
  -286
  -301
  -317
  -333
  -351
  -369
  -388
  -408
  -429
  -451
  -474
  -498
  -523
  -550
  -578
  -607
  -638
  -670
  -704
  -739
  -777
  -816
  -857
  -900
  -945
New CAPEX, $m
  -541
  -223
  -235
  -245
  -257
  -269
  -281
  -295
  -308
  -323
  -339
  -355
  -372
  -390
  -409
  -429
  -450
  -472
  -495
  -519
  -545
  -572
  -600
  -629
  -660
  -693
  -728
  -764
  -802
  -841
  -883
Cash from investing activities, $m
  -1,187
  -443
  -467
  -489
  -514
  -540
  -567
  -596
  -625
  -656
  -690
  -724
  -760
  -798
  -838
  -880
  -924
  -970
  -1,018
  -1,069
  -1,123
  -1,179
  -1,238
  -1,299
  -1,364
  -1,432
  -1,505
  -1,580
  -1,659
  -1,741
  -1,828
Free cash flow, $m
  101
  1,099
  1,152
  1,208
  1,267
  1,329
  1,393
  1,461
  1,531
  1,605
  1,682
  1,661
  1,745
  1,834
  1,927
  2,024
  2,127
  2,234
  2,346
  2,464
  2,587
  2,717
  2,853
  2,995
  3,145
  3,302
  3,466
  3,639
  3,821
  4,011
  4,211
Issuance/(repayment) of debt, $m
  712
  312
  330
  346
  361
  378
  396
  415
  434
  455
  477
  500
  524
  549
  576
  604
  633
  664
  697
  731
  767
  805
  844
  886
  930
  976
  1,024
  1,075
  1,128
  1,184
  1,243
Issuance/(repurchase) of shares, $m
  -344
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -87
  312
  330
  346
  361
  378
  396
  415
  434
  455
  477
  500
  524
  549
  576
  604
  633
  664
  697
  731
  767
  805
  844
  886
  930
  976
  1,024
  1,075
  1,128
  1,184
  1,243
Total cash flow (excl. dividends), $m
  12
  1,410
  1,482
  1,554
  1,629
  1,707
  1,789
  1,875
  1,965
  2,060
  2,159
  2,160
  2,269
  2,383
  2,503
  2,628
  2,760
  2,898
  3,043
  3,194
  3,354
  3,521
  3,697
  3,881
  4,075
  4,278
  4,491
  4,714
  4,949
  5,195
  5,454
Retained Cash Flow (-), $m
  -283
  -250
  -261
  -273
  -285
  -298
  -312
  -327
  -343
  -359
  -376
  -394
  -413
  -433
  -454
  -476
  -499
  -524
  -550
  -577
  -605
  -635
  -666
  -699
  -734
  -770
  -808
  -848
  -890
  -934
  -981
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  1,161
  1,222
  1,281
  1,343
  1,409
  1,477
  1,548
  1,623
  1,701
  1,783
  1,766
  1,856
  1,950
  2,048
  2,152
  2,260
  2,374
  2,493
  2,618
  2,749
  2,887
  3,031
  3,182
  3,341
  3,508
  3,683
  3,866
  4,059
  4,261
  4,473
Discount rate, %
 
  7.00
  7.35
  7.72
  8.10
  8.51
  8.93
  9.38
  9.85
  10.34
  10.86
  11.40
  11.97
  12.57
  13.20
  13.86
  14.55
  15.28
  16.04
  16.85
  17.69
  18.57
  19.50
  20.48
  21.50
  22.58
  23.70
  24.89
  26.13
  27.44
  28.81
PV of cash for distribution, $m
 
  1,085
  1,060
  1,025
  984
  936
  884
  826
  765
  701
  636
  538
  478
  418
  361
  307
  257
  212
  171
  136
  106
  81
  60
  44
  31
  22
  15
  10
  6
  4
  2
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Universal Health Services, Inc. is a holding company. The Company's principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company's segments include Acute Care Hospital Services, Behavioral Health Services and Other. As of February 28, 2017, the Company owned and/or operated 319 inpatient facilities, and 33 outpatient and other facilities, located in 37 states, Washington, District of Columbia, the United Kingdom, Puerto Rico and the United States Virgin Islands. The Company's hospitals provide a range of services, such as oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of February 28, 2017, its acute care facilities located in the United States included 26 inpatient acute care hospitals; four free-standing emergency departments, and four outpatient surgery/cancer care centers and one surgical hospital.

FINANCIAL RATIOS  of  Universal Health Services Cl B (UHS)

Valuation Ratios
P/E Ratio 16.3
Price to Sales 1.2
Price to Book 2.5
Price to Tangible Book
Price to Cash Flow 8.9
Price to Free Cash Flow 15.3
Growth Rates
Sales Growth Rate 8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 42.7%
Cap. Spend. - 3 Yr. Gr. Rate 5.8%
Financial Strength
Quick Ratio 0
Current Ratio 0.1
LT Debt to Equity 88.9%
Total Debt to Equity 91.2%
Interest Coverage 12
Management Effectiveness
Return On Assets 7.7%
Ret/ On Assets - 3 Yr. Avg. 7.7%
Return On Total Capital 8.6%
Ret/ On T. Cap. - 3 Yr. Avg. 8.6%
Return On Equity 16%
Return On Equity - 3 Yr. Avg. 16.2%
Asset Turnover 1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 17.2%
EBITDA Margin - 3 Yr. Avg. 17.7%
Operating Margin 13.1%
Oper. Margin - 3 Yr. Avg. 13.3%
Pre-Tax Margin 11.8%
Pre-Tax Margin - 3 Yr. Avg. 11.9%
Net Profit Margin 7.2%
Net Profit Margin - 3 Yr. Avg. 7.1%
Effective Tax Rate 35.4%
Eff/ Tax Rate - 3 Yr. Avg. 34.9%
Payout Ratio 5.6%

UHS stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the UHS stock intrinsic value calculation we used $9766 million for the last fiscal year's total revenue generated by Universal Health Services Cl B. The default revenue input number comes from 2016 income statement of Universal Health Services Cl B. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our UHS stock valuation model: a) initial revenue growth rate of 5.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7%, whose default value for UHS is calculated based on our internal credit rating of Universal Health Services Cl B, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Universal Health Services Cl B.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of UHS stock the variable cost ratio is equal to 86.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for UHS stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Universal Health Services Cl B.

Corporate tax rate of 27% is the nominal tax rate for Universal Health Services Cl B. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the UHS stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for UHS are equal to 41.8%.

Life of production assets of 18.6 years is the average useful life of capital assets used in Universal Health Services Cl B operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for UHS is equal to 4.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4533 million for Universal Health Services Cl B - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 95.809 million for Universal Health Services Cl B is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Universal Health Services Cl B at the current share price and the inputted number of shares is $11.3 billion.

RELATED COMPANIES Price Int.Val. Rating
CYH Community Heal 5.21 39.82  str.buy
THC Tenet Healthca 17.24 27.88  str.buy
HCA HCA Healthcare 93.01 33.99  str.sell
ACHC Acadia Healthc 34.01 35.16  hold
QHC Quorum Health 6.85 14.36  str.buy

COMPANY NEWS

▶ Top Dividend Paying Stocks   [Jan-18-18 08:02AM  Simply Wall St.]
▶ Universal Health Services, Inc. Announces Dividend   [Jan-17-18 05:52PM  PR Newswire]
▶ Great Real Estate Dividend Stocks For Every Portfolio   [Jan-15-18 10:02AM  Simply Wall St.]
▶ December Dividend Stocks To Look Out For   [Dec-10-17 08:02AM  Simply Wall St.]
▶ CVS buys Aetna for $69B   [Dec-04-17 10:56AM  Yahoo Finance Video]
▶ Soon-to-open behavioral health hospital names CEO   [Nov-29-17 12:55PM  American City Business Journals]
▶ New Strong Sell Stocks for November 20th   [Nov-20-17 08:18AM  Zacks]
▶ New Strong Sell Stocks for October 31st   [Oct-31-17 11:08AM  Zacks]
▶ CVS in talks to buy Aetna: RPTS   [10:31AM  Yahoo Finance Video]
▶ Universal Health Realty reports 3Q results   [Oct-26-17 07:32PM  Associated Press]
▶ Universal Health Services posts 3Q profit   [04:49PM  Associated Press]
▶ Should You Buy Universal Health Services Inc (UHS)?   [Sep-13-17 01:55PM  Simply Wall St.]
▶ The Biggest Loser: Envision Healthcare Tumbles 4.2%   [Sep-06-17 04:50PM  Barrons.com]
▶ Universal Health Services posts 2Q profit   [Jul-25-17 09:32PM  Associated Press]
▶ Universal Health Services, Inc. Announces Dividend   [Jul-19-17 05:00PM  PR Newswire]
▶ OHA issues final denial of Wilsonville psychiatric proposal; UHS to appeal   [Jul-14-17 11:15AM  American City Business Journals]
▶ [$$] Anthem Pulling Back on Offering ACA Plans in Nevada   [Jun-28-17 08:46PM  The Wall Street Journal]
▶ These 3 Stocks Just Raised Their Dividends   [Jun-15-17 09:40AM  Motley Fool]
▶ UHS faults Oregon's reasoning behind delay of psychiatric hospital decision   [Jun-13-17 06:14PM  American City Business Journals]
▶ State approves for-profit firms new hospital in partnership with University of Miami   [Jun-05-17 03:15PM  American City Business Journals]
▶ Universal Health Services, Inc. Announces Dividend   [May-17-17 05:12PM  PR Newswire]
Financial statements of UHS
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.